WORK PACKAGE 4
The role of social costs in economic evaluations of health care decisions in Europe
Identify the proportion of economic evaluation incorporating labour productivity losses and non-healthcare costs
Identify pathologies where it is more frequent to include social costs in economic evaluations
Identify the countries where it is more frequent the inclusion of social costs in economic evaluations
Compare the results of the economic evaluations achieved in case studies that incorporate social costs with the results of the studies not including social costs in the same studies
Identify the methodology used in the assessment of labour productivity losses, formal and informal care.
Elaborate a repository on unit costs in Europe of lost work time and the value of informal care time (coordinated part with WP3).
Literature review: Revising the methodological aspects related to applied to the identification, measurement and valuation of social costs, especially, labour losses and informal care cost in economic evaluations
Case studies: Quantifying different ways of incorporating the social perspective into economic analysis to inform European decisions
European Database: Creating a database on unit costs in Europe of lost work time and the value of informal and formal care time (coordinated part with WP3).
A review of the methodological aspects applied to the identification, measurement and valuation of social costs (especially, labour losses and informal care cost) in economic evaluations
A series of selected case studies to quantify important different ways of incorporating the social perspective into economic analysis to inform European decisions. These case studies will allow the testing and refinement of the WP outputs.
Core dataset of social costs and link this to the dataset proposed in WP3, which will contain all cost items with a manual on how to use them. The database will be designed and developed in a way that allows its future updating and continuity after the end of the present project.
European Healthcare and Social Cost Database (EU HCCD)
The EU HCCD provides a core dataset of costs across countries. It allows analysis of variations in costs within/across countries (taking into account differences between healthcare systems and other factors) and health economic evaluations (by transfer of economic evaluation analysis and models across countries). Additionally, it facilitates multi-country studies and the adaptation of economic evaluation studies from country to country by reducing the time/costs of finding healthcare costs.
Access the database HERE.
June 2019 – How relevant are social costs in economic evaluations? The case of Alzheimer’s disease, JORNADAS DE ECONOMÍA DE LA SALUD 2019 (PDF)
Peña-Longobardo LM, Rodríguez-Sánchez B, Oliva-Moreno J, Aranda-Reneo I, López-Bastida J. (2019). How relevant are social costs in economic evaluations? The case of Alzheimer’s disease. The European Journal of Health Economics, 20(8), 1207–1236. (https://doi.org/10.1007/s10198-019-01087-6)
November 2019 – How relevant are social costs in economic evaluations? The case of Rare Diseases – ISPOR 2019 (Poster PDF)
January 2020 – IMPACT HTA 3rd Project Meeting (Presentation PPT)
Juliane Andrea Duevel, Lena Hasemann, Luz Maria Peña-Longobardo, Beatriz Rodríguez-Sánchez, Isaac Aranda-Reneo, Juan Oliva-Moreno, Julio López-Bastida, Wolfgang Greiner (2020). Considering the societal perspective in economic evaluations: a systematic review in the case of depression. Health Economics Review, 2020,10 (1):32 (https://doi.org/10.1186/s13561-020-00288-7)
November 2020– Assessing the effect of including social costs in economic evaluations: A systematic review of diabetes-related interventions – ISPOR 2020 (Poster PDF)
November 2020 – Considering the societal perspective in economic evaluations: a systematic review in the case of depression – ISPOR 2020 (Poster PDF)
November 2020 – Social costs in multiple sclerosis economic evaluations: do their inclusion change the results and conclusions? A systematic review – ISPOR 2020 (Poster PDF)
Aranda-Reneo I, Rodríguez-Sánchez B, Peña-Longobardo LM, Oliva-Moreno J, López-Bastida J. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis. Value Health. 2021 Mar;24(3):431-442. doi: 10.1016/j.jval.2020.10.014. Epub 2020 Dec 5. PMID: 33641778. (Read on PubMed)
University Castilla-La Mancha